It starts with a story we’ve heard too often in international pharma corridors. A buyer from Nairobi shortlists three Indian suppliers for a tender on essential antibiotics. All three are competitive in price, equally confident, and seemingly reliable. Yet only one of them ends up signing the long-term supply agreement. What made the difference?